2 completed, 1 unknown. 2 Phase 1, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Early Phase 1 | 1 | Unknown 1 |
Follow Lexaria Bioscience Corp.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants Arm 1 - DehydraTECH-CBD alone, Arm 2 - DehydraTECH-semaglutide alone, Arm 3 - DehydraTECH-CBD in combination with DehydraTECH-semaglutide - Type2diabetes | Phase 1 | Completed | Lexaria Bioscience Corp. | 148 | 2024-12-04 | 2026-01-12 |
| Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients Cannabidiol, Placebo - Hypertension | Phase 1 | Completed | University of Split, School of Medicine | 70 | 2022-04-08 | 2023-05-16 |
| Cannabinoid Supplementation on Vascular and Cognitive Function Cannabidiol supplement - Diet Modification | Early Phase 1 | Unknown | University of British Columbia | 24 | 2018-01-01 | 2019-10-23 |
Hypertension (1)
Cannabidiol (1) · Single Person (1) · semaglutide (1)
Australia (1) · Canada (1) · Croatia (1)